LSU Health Sciences Center says people with a common, hard-to-treat kind of lung cancer can join a new national trial to test drugs faster.
NEW ORLEANS (AP) - LSU Health Sciences Center says people with a common, hard-to-treat kind of lung cancer can join a new national trial to test drugs faster.
Patients with advanced squamous (SKWAY-muhs) cell lung cancer can enroll at LSU cancer centers in New Orleans, Houma, Covington and Baton Rouge.
Most such clinical trials test one drug that may affect one cancer gene. The Lung Cancer Master Protocol, or Lung-MAP, gives full gene tests, with five new drugs available. Doctors will assign each patient to the test of the drug with the best chance of helping.
Organizers want to enroll 10,000 people nationwide.
They say 85 locations began enrollment in June and 169 more by Wednesday. LSU is among 24 hospitals and groups on their list.
LSU announced its participation Thursday.